Daniel Joseph Apel, CFO: Arrowhead Pharmaceuticals ARWR Sell · Filed 04/24

Trade details

Type: Insider sale
Amount: $81,510.65
Shares · price: 1,157 sh · $70.45 a share
Held after: 171,635 sh
Stock: Arrowhead Pharmaceuticals ARWR
Person: Daniel Joseph ApelCFO
Trade date: 26/04/22
Filed: 26/04/24
Days to filing: 2 days

Sold 0.7% of holdings

Share of holding sold: 0.7%

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 03/23~05/22

Daniel Joseph Apel's recent trades

Daniel Joseph ApelCFO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$627.9K
8,730 sh
$627.9K
Filed 04/24
Traded 04/22
Daniel Joseph ApelCFO
Sell10b5-1 planArrowhead Pharmaceuticals
Sell10b5-1 plan
Arrowhead Pharmaceuticals
ARWR
$224.9K
3,208 sh
$224.9K
Filed 04/24
Traded 04/22
Daniel Joseph ApelCFO
Planned saleArrowhead Pharmaceuticals
Planned sale
Arrowhead Pharmaceuticals
ARWR
$934.2K
13,095 sh
$934.2K
Filed 04/22
Traded 04/22

Daniel Joseph Apel, CFO — sold $81.5K of Arrowhead Pharmaceuticals ARWR · 0.7% of holdings · 10b5-1 plan | Whalegun